A severe form of congenital disorders of N-linked glycosylation characterized by severe developmental and psychomotor delay, muscular hypotonia, intractable early-onset seizures, and microcephaly. Additional features include altered blood coagulation with a high probability of hemorrhages or thromboses, nephrotic syndrome, ascites, hepatomegaly, cardiomyopathy, ocular manifestations (strabismus, nystagmus), and immunodeficiency. The disease is caused by loss-of-function mutations in the gene ALG1 (16p13.3).
Comprehensive, easy-to-understand information about this condition
Checking for content...
PMM2-congenital disorder of glycosylation
MONDO:0008907
MGAT2-congenital disorder of glycosylation
MONDO:0008908
developmental and epileptic encephalopathy, 36
MONDO:0010472
SSR4-congenital disorder of glycosylation
MONDO:0010490
ALG3-congenital disorder of glycosylation
MONDO:0010998
MPI-congenital disorder of glycosylation
MONDO:0011257